β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceKey Metrics
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Per Share | Net Income Per Share | Operating Cash Flow Per Share | Free Cash Flow PerShare | Cash Per Share | Book Value Per Share | Tangible Book Value Per Share | Shareholders Equity Per Share | Interest Debt Per Share | Market Cap | Enterprise Value | P/E Ratio | Price To Sales Ratio | POCF ratio | PFCF Ratio | P/B Ratio | PTB Ratio | EV To Sales | Enterprise Value Over EBITDA | EV To Operating Cash Flow | EV To Free Cash Flow | Earnings Yield | Free Cash Flow Yield | Debt To Equity | Debt To Assets | Net Debt To EBITDA | Current Ratio | Interest Coverage | Income Quality | Dividend Yield | Payout Ratio | Sales General And Administrative To Revenue | R&D To Revenue | Intangibles To Total Assets | CAPEX To Operating Cash Flow | CAPEX To Revenue | CAPEX To Depreciation | Stock Based Compensation To Revenue | Graham Number | ROIC | Return On Tangible Assets | Graham Net-Net | Working Capital | Tangible Asset Value | Net Current Asset Value | Invested Capital | Average Receivables | Average Payables | Average Inventory | Days Sales Outstanding | Days Payables Outstanding | Days Of Inventory On Hand | Receivables Turnover | Payables Turnover | Inventory Turnover | ROE | CAPEX Per Share |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03 | 823.04 | 72.62 | 198.01 | 168.88 | 258.83 | 832.32 | 603.86 | 834.19 | 103.09 | 520983800000 | 461559800000 | 19.55 | 1.73 | 7.17 | 8.41 | 1.7 | 1.7 | 1.53 | 8.18 | 6.35 | 7.45 | 0.05 | 0.12 | 0.11 | 0.08 | -1.05 | 2.54 | 14.47 | 2.72 | 0.02 | 0.45 | 0.3 | 0.08 | 0.19 | 0.15 | 0.04 | 0.59 | 0 | 1167.45 | 0.1 | 0.08 | 147.53 | 143343000000 | 221550000000 | 105809000000 | 298738000000 | 98852000000 | 24662000000 | 41268500000 | 109.44 | 63.55 | 114.15 | 3.34 | 5.74 | 3.2 | 0.09 | 29.13 |
2023-03 | 720.24 | -38.58 | 95.88 | 32.42 | 151.46 | 757.05 | 508.46 | 758.81 | 97.33 | 437784600000 | 416088600000 | -29.29 | 1.57 | 11.79 | 34.86 | 1.49 | 1.49 | 1.49 | 29.1 | 11.2 | 33.13 | -0.03 | 0.03 | 0.12 | 0.09 | -1.52 | 2.38 | -2.06 | -2.48 | 0.03 | -0.84 | 0.34 | 0.1 | 0.23 | 0.66 | 0.09 | 1.43 | 0 | 0 | -0.02 | -0.05 | 79.62 | 123822000000 | 196988000000 | 85444000000 | 286304000000 | 103378000000 | 24851000000 | 38246500000 | 140.18 | 81.7 | 127.17 | 2.6 | 4.47 | 2.87 | -0.05 | 63.47 |
2022-03 | 666.02 | 68.08 | 115.17 | 25.52 | 210.89 | 842.58 | 516.86 | 844.19 | 85.4 | 490523925000 | 440441925000 | 18.02 | 1.84 | 10.65 | 48.08 | 1.45 | 1.45 | 1.65 | 8.08 | 9.57 | 43.17 | 0.06 | 0.02 | 0.1 | 0.07 | -0.92 | 2.39 | 29.68 | 1.69 | 0.02 | 0.44 | 0.32 | 0.1 | 0.28 | 0.78 | 0.13 | 2.1 | 0 | 1137.19 | 0.08 | 0.08 | 136.17 | 133605000000 | 206627000000 | 106294000000 | 320109000000 | 97791500000 | 24339500000 | 39358000000 | 136.52 | 81.27 | 123.61 | 2.67 | 4.49 | 2.95 | 0.08 | 89.65 |
2021-03 | 624.86 | 17.1 | 97.15 | 37.56 | 158.75 | 768.67 | 486.1 | 770.01 | 29.12 | 608371488000 | 555629488000 | 89.07 | 2.44 | 15.68 | 40.55 | 1.98 | 1.98 | 2.23 | 18.52 | 14.32 | 37.03 | 0.01 | 0.02 | 0.03 | 0.03 | -1.76 | 2.63 | 8.68 | 5.84 | 0.02 | 1.64 | 0.32 | 0.1 | 0.28 | 0.61 | 0.1 | 1.42 | 0 | 544.27 | 0.02 | 0.02 | 152.44 | 127682000000 | 194174000000 | 110928000000 | 280047000000 | 91495500000 | 23073000000 | 38428500000 | 140.37 | 90.15 | 154.5 | 2.6 | 4.05 | 2.36 | 0.02 | 59.59 |
2020-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-03 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more key metrics for Santen Pharmaceutical!
Sign up for free or log inπ Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!